Lonza expanding ADC production as pharma business thrives
Swiss CDMO may be struggling in some areas, but it is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth. The CDMO today said it will expand its bioconjugation facility in Visp, Switzerland even as the facility was approved for the third time for production… Read More »